Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
2002 1
2011 1
2012 1
2015 1
2018 5
2019 5
2020 6
2021 9
2022 10
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.
Wu Y, Terekhanova NV, Caravan W, Naser Al Deen N, Lal P, Chen S, Mo CK, Cao S, Li Y, Karpova A, Liu R, Zhao Y, Shinkle A, Strunilin I, Weimholt C, Sato K, Yao L, Serasanambati M, Yang X, Wyczalkowski M, Zhu H, Zhou DC, Jayasinghe RG, Mendez D, Wendl MC, Clark D, Newton C, Ruan Y, Reimers MA, Pachynski RK, Kinsinger C, Jewell S, Chan DW, Zhang H, Chaudhuri AA, Chheda MG, Humphreys BD, Mesri M, Rodriguez H, Hsieh JJ, Ding L, Chen F. Wu Y, et al. Among authors: pachynski rk. Nat Commun. 2023 Mar 27;14(1):1681. doi: 10.1038/s41467-023-37211-7. Nat Commun. 2023. PMID: 36973268 Free PMC article.
Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial.
Sharma P, Pachynski RK, Narayan V, Fléchon A, Gravis G, Galsky MD, Mahammedi H, Patnaik A, Subudhi SK, Ciprotti M, Simsek B, Saci A, Hu Y, Han GC, Fizazi K. Sharma P, et al. Among authors: pachynski rk. Cancer Cell. 2020 Oct 12;38(4):489-499.e3. doi: 10.1016/j.ccell.2020.08.007. Epub 2020 Sep 10. Cancer Cell. 2020. PMID: 32916128 Free article. Clinical Trial.
Reply by Authors.
Crawford ED, Garnick MB, Eckel RH, Miner MM, Freedland SJ, Pachynski RK, Wassersug RJ, Rosenberg MT, Walker LM, Fairman C, Curley T, Crosby M, Lin PH, Hafron JM. Crawford ED, et al. Among authors: pachynski rk. Urol Pract. 2024 Jan;11(1):30-31. doi: 10.1097/UPJ.0000000000000473.02. Epub 2023 Nov 6. Urol Pract. 2024. PMID: 38051218 No abstract available.
Treatment of Advanced Prostate Cancer.
Thomas TS, Pachynski RK. Thomas TS, et al. Among authors: pachynski rk. Mo Med. 2018 Mar-Apr;115(2):156-161. Mo Med. 2018. PMID: 30228709 Free PMC article. Review.
First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma.
Strauss J, Deville JL, Sznol M, Ravaud A, Maruzzo M, Pachynski RK, Gourdin TS, Maio M, Dirix L, Schlom J, Donahue RN, Tsai YT, Wang X, Vugmeyster Y, Beier F, Seebeck J, Schroeder A, Chennoufi S, Gulley JL. Strauss J, et al. Among authors: pachynski rk. J Immunother Cancer. 2023 May;11(5):e005813. doi: 10.1136/jitc-2022-005813. J Immunother Cancer. 2023. PMID: 37236636 Free PMC article. Clinical Trial.
How else can we approach prostate cancer biomarker discovery?
Drake RR, Angel PM, Wu J, Pachynski RK, Ippolito JE. Drake RR, et al. Among authors: pachynski rk. Expert Rev Mol Diagn. 2020 Feb;20(2):123-125. doi: 10.1080/14737159.2019.1665507. Epub 2019 Sep 10. Expert Rev Mol Diagn. 2020. PMID: 31498690 Free PMC article. No abstract available.
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance.
Sridaran D, Chouhan S, Mahajan K, Renganathan A, Weimholt C, Bhagwat S, Reimers M, Kim EH, Thakur MK, Saeed MA, Pachynski RK, Seeliger MA, Miller WT, Feng FY, Mahajan NP. Sridaran D, et al. Among authors: pachynski rk. Nat Commun. 2022 Nov 14;13(1):6929. doi: 10.1038/s41467-022-34724-5. Nat Commun. 2022. PMID: 36376335 Free PMC article.
Chemerin triggers migration of a CD8 T cell subset with natural killer cell functions.
Ballet R, LaJevic M, Huskey-Mullin N, Roach R, Brulois K, Huang Y, Saeed MA, Dang HX, Pachynski RK, Wilson E, Butcher EC, Zabel BA. Ballet R, et al. Among authors: pachynski rk. Mol Ther. 2023 Oct 4;31(10):2887-2900. doi: 10.1016/j.ymthe.2023.08.015. Epub 2023 Aug 28. Mol Ther. 2023. PMID: 37641406 Free article.
48 results